Dr. ID: 50186

Stadt zur Stadt

graph of relations

Publications

  1. 2023
  2. ABL-class Genomic Breakpoint Q-PCR: A Patient-specific Approach for MRD Monitoring in Acute Lymphoblastic Leukemia

    van Outersterp, I., van der Velden, V. H. J., Hoogeveen, P. G., Vaitkevičienė, G. E., Sonneveld, E., van Haaften, G., Kuiper, R. P., Zur Stadt, U., Escherich, G., Boer, J. M. & den Boer, M. L., 10.2023, In: HEMASPHERE. 7, 10, p. e967

    Research output: SCORING: Contribution to journalLetterResearchpeer-review

  3. 2022
  4. Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trial

    Mezger, K., Ebert, S., Muhle, H. E., Stadt, U. Z., Borkhardt, A., Dilloo, D., Faber, J., Feuchtinger, T., Imschweiler, T., Jorch, N., Pekrun, A., Schmid, I., Schramm, F., Zimmermann, M., Horstmann, M. A. & Escherich, G., 12.2022, In: PEDIATR BLOOD CANCER. 69, 12, e29997.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

    Möker, P., Zur Stadt, U., Zimmermann, M., Alawi, M., Mueller, S., Finger, J., Knörr, F., Riquelme, A., Oschlies, I., Klapper, W., Bradtke, J., Burkhardt, B., Woessmann, W. & Damm-Welk, C., 09.2022, In: LEUKEMIA. 36, 9, p. 2343-2346 4 p.

    Research output: SCORING: Contribution to journalLetterResearch

  6. Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group

    Escherich, G., Zur Stadt, U., Borkhardt, A., Dilloo, D., Faber, J., Feuchtinger, T., Imschweiler, T., Jorch, N., Pekrun, A., Schmid, I., Schramm, F., Spohn, M., Zimmermann, M. & Horstmann, M. A., 01.05.2022, In: HAEMATOLOGICA. 107, 5, p. 1026-1033 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2021
  8. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study

    Michels, N., Boer, J. M., Enshaei, A., Sutton, R., Heyman, M., Ebert, S., Fiocco, M., de Groot-Kruseman, H. A., van der Velden, V. H. J., Barbany, G., Escherich, G., Vora, A., Trahair, T., Dalla-Pozza, L., Pieters, R., Zur Stadt, U., Schmiegelow, K., Moorman, A. V., Zwaan, C. M. & den Boer, M. L., 10.2021, In: LANCET HAEMATOL. 8, 10, p. e700-e710

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. 2020
  10. Ulceration in Prolidase Deficiency: Successful Treatment with Anticoagulants

    Süßmuth, K., Metze, D., Muresan, A-M., Lehmberg, K., Zur Stadt, U., Speckmann, C., Park, J. H., Marquardt, T., Oji, V. & Goerge, T., 07.01.2020, In: ACTA DERM-VENEREOL. 100, 1, p. adv00002

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. Functional flow cytometry of monocytes for routine diagnosis of innate primary immunodeficiencies

    Ammann, S., Fuchs, S., Martin-Martin, L., Castro, C. N., Spielberger, B., Klemann, C., Elling, R., Heeg, M., Speckmann, C., Hainmann, I., Kaiser-Labusch, P., Horneff, G., Thalhammer, J., Bredius, R. G., Stadt, U. Z., Lehmberg, K., Fuchs, I., von Spee-Mayer, C., Henneke, P. & Ehl, S., 01.2020, In: J ALLERGY CLIN IMMUN. 145, 1, p. 434-437.e4

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  12. 2019
  13. Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL

    Zur Stadt, U., Alawi, M., Adao, M., Indenbirken, D., Escherich, G. & Horstmann, M. A., 29.11.2019, In: BLOOD CANCER J. 9, 12, p. 96

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Results of CoALL 07-03 study childhood ALL based on combined risk assessment by in vivo and in vitro pharmacosensitivity

    Schramm, F., Zur Stadt, U., Zimmermann, M., Jorch, N., Pekrun, A., Borkhardt, A., Imschweiler, T., Christiansen, H., Faber, J., Schmid, I., Feuchtinger, T., Beron, G., den Boer, M. L., Pieters, R., Horstmann, M. A., Janka-Schaub, G. E. & Escherich, G., 26.11.2019, In: Blood Adv. 3, 22, p. 3688-3699 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets

    Hoell, J. I., Ginzel, S., Kuhlen, M., Kloetgen, A., Gombert, M., Fischer, U., Hein, D., Demir, S., Stanulla, M., Schrappe, M., Zur Stadt, U., Bader, P., Babor, F., Schuster, F., Strahm, B., Alten, J., Moericke, A., Escherich, G., von Stackelberg, A., Thiele, R., McHardy, A. C., Peters, C., Bornhauser, B., Bourquin, J-P., Krause, S., Enczmann, J., Meyer, L. H., Eckert, C., Borkhardt, A. & Meisel, R., 22.10.2019, In: Blood Adv. 3, 20, p. 3143-3156 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia

    Hoffmann, J., Krumbholz, M., Gutiérrez, H. P., Fillies, M., Szymansky, A., Bleckmann, K., Zur Stadt, U., Köhler, R., Kuiper, R. P., Horstmann, M., von Stackelberg, A., Eckert, C. & Metzler, M., 08.2019, In: PEDIATR BLOOD CANCER. 66, 8, p. e27780

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. IKZF1 Deletions with COBL Breakpoints Are Not Driven by RAG-Mediated Recombination Events in Acute Lymphoblastic Leukemia

    Lopes, B. A., Meyer, C., Barbosa, T. C., Poubel, C. P., Mansur, M. B., Duployez, N., Bashton, M., Harrison, C. J., Zur Stadt, U., Horstmann, M., Pombo-de-Oliveira, M. S., Palmi, C., Cazzaniga, G., Venn, N. C., Sutton, R., Alonso, C. N., Tsaur, G., Gupta, S. K., Bakhshi, S., Marschalek, R. & Emerenciano, M., 05.2019, In: TRANSL ONCOL. 12, 5, p. 726-732 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. 2018
  19. Is an infectious trigger always required for primary hemophagocytic lymphohistiocytosis? Lessons from in utero and neonatal disease

    Heeg, M., Ammann, S., Klemann, C., Panning, M., Falcone, V., Hengel, H., Lehmberg, K., Zur Stadt, U., Wustrau, K., Janka, G. & Ehl, S., 01.08.2018, In: PEDIATR BLOOD CANCER. 65, 11, p. e27344

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

    Cazzaniga, G., De Lorenzo, P., Alten, J., Röttgers, S., Hancock, J., Saha, V., Castor, A., Madsen, H. O., Gandemer, V., Cavé, H., Leoni, V., Köhler, R., Ferrari, G. M., Bleckmann, K., Pieters, R., van der Velden, V., Stary, J., Zuna, J., Escherich, G., Stadt, U. Z., Aricò, M., Conter, V., Schrappe, M., Valsecchi, M. G. & Biondi, A., 01.2018, In: HAEMATOLOGICA. 103, 1, p. 107-115 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. 2017
  22. Hemophagocytic lymphohistiocytosis as presenting manifestation of profound combined immunodeficiency due to an ORAI1 mutation

    Klemann, C., Ammann, S., Heizmann, M., Fuchs, S., Bode, S. F., Heeg, M., Fuchs, H., Lehmberg, K., Zur Stadt, U., Roll, C., Vraetz, T., Speckmann, C., Lorenz, M. R., Schwarz, K., Rohr, J., Feske, S. & Ehl, S., 12.2017, In: J ALLERGY CLIN IMMUN. 140, 6, p. 1721-1724 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  23. Effective Immunological Guidance of Genetic Analyses Including Exome Sequencing in Patients Evaluated for Hemophagocytic Lymphohistiocytosis

    Ammann, S., Lehmberg, K., Zur Stadt, U., Klemann, C., Bode, S. F. N., Speckmann, C., Janka, G., Wustrau, K., Rakhmanov, M., Fuchs, I., Hennies, H. C., Ehl, S. & HLH study of the GPOH, 11.2017, In: J CLIN IMMUNOL. 37, 8, p. 770-780 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Lineage switch under blinatumomab treatment of relapsed common acute lymphoblastic leukemia without MLL rearrangement

    Zoghbi, A., Zur Stadt, U., Winkler, B., Müller, I. & Escherich, G., 11.2017, In: PEDIATR BLOOD CANCER. 64, 11, p. 11

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. The role of constitutive activation of FMS-related tyrosine kinase-3 andmutational status in infants with-rearranged acute lymphoblastic leukemia

    Fedders, H., Alsadeq, A., Schmäh, J., Vogiatzi, F., Zimmermann, M., Möricke, A., Lenk, L., Stadt, U. Z., Horstmann, M. A., Pieters, R., Schrappe, M., Stanulla, M., Cario, G. & Schewe, D. M., 11.2017, In: HAEMATOLOGICA. 102, 11, p. e438-e442

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia

    Vesely, C., Frech, C., Eckert, C., Cario, G., Mecklenbräuker, A., Zur Stadt, U., Nebral, K., Kraler, F., Fischer, S., Attarbaschi, A., Schuster, M., Bock, C., Cavé, H., von Stackelberg, A., Schrappe, M., Horstmann, M. A., Mann, G., Haas, O. A. & Panzer-Grümayer, R., 07.2017, In: LEUKEMIA. 31, 7, p. 1491-1501

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire

    Ammann, S., Lehmberg, K., Zur Stadt, U., Janka-Schaub, G., Rensing-Ehl, A., Klemann, C., Heeg, M., Bode, S., Fuchs, I., Ehl, S. & HLH study of the GPOH, 02.2017, In: EUR J IMMUNOL. 47, 2, p. 364-373

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2016
  29. COBL is a novel hotspot for IKZF1 deletions in childhood acute lymphoblastic leukemia

    Lopes, B. A., Meyer, C., Barbosa, T. C., Stadt, U. Z., Horstmann, M., Venn, N. C., Heatley, S., White, D. L., Sutton, R., Pombo-de-Oliveira, M. S., Marschalek, R. & Emerenciano, M., 13.07.2016, In: ONCOTARGET. 7, 33, p. 53064-53073

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Rapid Capture Next-Generation Sequencing in Clinical Diagnostics of Kinase Pathway Aberrations in B-Cell Precursor ALL

    Stadt, U. Z., Escherich, G., Indenbirken, D., Alawi, M., Adao, M. & Horstmann, M. A., 23.03.2016, In: PEDIATR BLOOD CANCER. 63, 7, p. 1283-6

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  31. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome

    Ammann, S., Schulz, A., Krägeloh-Mann, I., Dieckmann, N. M. G., Niethammer, K., Fuchs, S., Eckl, K. M., Plank, R., Werner, R., Altmüller, J., Thiele, H., Nürnberg, P., Bank, J., Strauss, A., von Bernuth, H., Zur Stadt, U., Grieve, S., Griffiths, G. M., Lehmberg, K., Hennies, H. C. & Ehl, S., 25.02.2016, In: BLOOD. 127, 8, p. 997-1006 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. 2015
  33. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents

    Lehmberg, K., Sprekels, B., Nichols, K. E., Woessmann, W., Müller, I., Suttorp, M., Bernig, T., Beutel, K., Bode, S. F. N., Kentouche, K., Kolb, R., Längler, A., Minkov, M., Schilling, F. H., Schmid, I., Vieth, S., Ehl, S., Zur Stadt, U. & Janka, G. E., 08.2015, In: BRIT J HAEMATOL. 170, 4, p. 539-49 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Late-onset hemophagocytic lymphohistiocytosis (HLH) in an adult female with Griscelli syndrome type 2 (GS2)

    Henkes, M., Finke, J., Warnatz, K., Ammann, S., Stadt, U. Z., Janka-Schaub, G. & Brugger, W., 06.2015, In: ANN HEMATOL. 94, 6, p. 1057-60 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  35. KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia

    Malinowska-Ozdowy, K., Frech, C., Schönegger, A., Eckert, C., Cazzaniga, G., Stanulla, M., Zur Stadt, U., Mecklenbräuker, A., Schuster, M., Kneidinger, D., von Stackelberg, A., Locatelli, F., Schrappe, M., Horstmann, M. A., Attarbaschi, A., Bock, C., Mann, G., Haas, O. A. & Panzer-Grümayer, R., 28.04.2015, In: LEUKEMIA. 29, 8, p. 1656-1667

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Novel Patient with Late-Onset Familial Hemophagocytic Lymphohistiocytosis with STXBP2 Mutations Presenting with Autoimmune Hepatitis, Neurological Manifestations and Infections Associated with Hypogammaglobulinemia

    Esmaeilzadeh, H., Bemanian, M. H., Nabavi, M., Arshi, S., Fallahpour, M., Fuchs, I., Zur Stadt, U., Warnatz, K., Ammann, S., Ehl, S., Lehmberg, K. & Rezaei, N., 01.2015, In: J CLIN IMMUNOL. 35, 1, p. 22-25

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. 2014
  38. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency

    Ammann, S., Elling, R., Gyrd-Hansen, M., Dückers, G., Bredius, R., Burns, S. O., Edgar, J. D. M., Worth, A., Brandau, H., Warnatz, K., Zur Stadt, U., Hasselblatt, P., Schwarz, K., Ehl, S. & Speckmann, C., 01.06.2014, In: CLIN EXP IMMUNOL. 176, 3, p. 394-400 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. 2013
  40. The MLL recombinome of acute leukemias in 2013

    Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., Cavé, H., Clappier, E., Mass-Malo, K., Zuna, J., Trka, J., De Braekeleer, E., De Braekeleer, M., Oh, S. H., Tsaur, G., Fechina, L., van der Velden, V. H. J., van Dongen, J. J. M., Delabesse, E., Binato, R., Silva, M. L. M., Kustanovich, A., Aleinikova, O., Harris, M. H., Lund-Aho, T., Juvonen, V., Heidenreich, O., Vormoor, J., Choi, W. W. L., Jarosova, M., Kolenova, A., Bueno, C., Menendez, P., Wehner, S., Eckert, C., Talmant, P., Tondeur, S., Lippert, E., Launay, E., Henry, C., Ballerini, P., Lapillone, H., Callanan, M. B., Cayuela, J. M., Herbaux, C., Cazzaniga, G., Kakadiya, P. M., Bohlander, S., Ahlmann, M., Choi, J. R., Gameiro, P., Lee, D. S., Krauter, J., Cornillet-Lefebvre, P., Te Kronnie, G., Schäfer, B. W., Kubetzko, S., Alonso, C. N., zur Stadt, U., Sutton, R., Venn, N. C., Izraeli, S., Trakhtenbrot, L., Madsen, H. O., Archer, P., Hancock, J., Cerveira, N., Teixeira, M. R., Lo Nigro, L., Möricke, A., Stanulla, M., Schrappe, M., Sedék, L., Szczepański, T., Zwaan, C. M., Coenen, E. A., van den Heuvel-Eibrink, M. M., Strehl, S., Dworzak, M., Panzer-Grümayer, R., Dingermann, T., Klingebiel, T. & Marschalek, R., 01.11.2013, In: LEUKEMIA. 27, 11, p. 2165-76 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial

    Escherich, G., Zur Stadt, U., Zimmermann, M., Horstmann, M. A. & COALL study group, 01.10.2013, In: BRIT J HAEMATOL. 163, 2, p. 240-7 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis

    Speckmann, C., Lehmberg, K., Albert, M. H., Damgaard, R. B., Fritsch, M., Gyrd-Hansen, M., Rensing-Ehl, A., Vraetz, T., Grimbacher, B., Salzer, U., Fuchs, I., Ufheil, H., Belohradsky, B. H., Hassan, A., Cale, C. M., Elawad, M., Strahm, B., Schibli, S., Lauten, M., Kohl, M., Meerpohl, J. J., Rodeck, B., Kolb, R., Eberl, W., Soerensen, J., von Bernuth, H., Lorenz, M., Schwarz, K., zur Stadt, U. & Ehl, S., 01.10.2013, In: CLIN IMMUNOL. 149, 1, p. 133-41 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling

    Damgaard, R. B., Fiil, B. K., Speckmann, C., Yabal, M., zur Stadt, U., Bekker-Jensen, S., Jost, P. J., Ehl, S., Mailand, N. & Gyrd-Hansen, M., 01.08.2013, In: EMBO MOL MED. 5, 8, p. 1278-95 18 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Persistent defective membrane trafficking in epithelial cells of patients with familial hemophagocytic lymphohistiocytosis type 5 due to STXBP2/MUNC18-2 mutations

    Stepensky, P., Bartram, J., Barth, T. F., Lehmberg, K., Walther, P., Amann, K., Philips, A. D., Beringer, O., zur Stadt, U., Schulz, A., Amrolia, P., Weintraub, M., Debatin, K-M., Hoenig, M. & Posovszky, C., 01.07.2013, In: PEDIATR BLOOD CANCER. 60, 7, p. 1215-22 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2

    Jessen, B., Bode, S. F. N., Ammann, S., Chakravorty, S., Davies, G., Diestelhorst, J., Frei-Jones, M., Gahl, W. A., Gochuico, B. R., Griese, M., Griffiths, G., Janka-Schaub, G., Klein, C., Kögl, T., Kurnik, K., Lehmberg, K., Maul-Pavicic, A., Mumford, A. D., Pace, D., Parvaneh, N., Rezaei, N., de Saint Basile, G., Schmitt-Graeff, A., Schwarz, K., Karasu, G. T., Zieger, B., zur Stadt, U., Aichele, P. & Ehl, S., 11.04.2013, In: BLOOD. 121, 15, p. 2943-51 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease

    Kögl, T., Müller, J., Jessen, B., Schmitt-Graeff, A., Janka-Schaub, G., Ehl, S., zur Stadt, U. & Aichele, P., 24.01.2013, In: BLOOD. 121, 4, p. 604-13 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Refinement of IKZF1 recombination hotspots in pediatric BCP-ALL patients.

    Meyer, C., Zur Stadt, U., Escherich, G., Hofmann, J., Binato, R., Barbosa, T. D. C., Emerenciano, M., Pombo-de-Oliveira, M. S., Horstmann, M. & Marschalek, R., 2013, In: AM J BLOOD RES. 3, 2, p. 165-173 9 p., 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Syntaxin 11 is required for NK and CD8⁺ T-cell cytotoxicity and neutrophil degranulation.

    D'Orlando, O., Zhao, F., Kasper, B., Orinska, Z., Müller, J., Hermans-Borgmeyer, I., Griffiths, G. M., Zur Stadt, U. & Bulfone-Paus, S., 2013, In: EUR J IMMUNOL. 43, 1, p. 194-208 15 p., 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. 2012
  50. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5)

    Pagel, J., Beutel, K., Lehmberg, K., Koch, F., Maul-Pavicic, A., Rohlfs, A-K., Al-Jefri, A., Beier, R., Lilian, B. O., Ehlert, K., Gross-Wieltsch, U., Jorch, N., Kremens, B., Pekrun, A., Sparber-Sauer, M., Mejstrikova, E., Wawer, A., Ehl, S., Zur Stadt, U. & Janka-Schaub, G., 21.06.2012, In: BLOOD. 119, 25, p. 6016-6024 9 p., 25.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.

    Bryceson, Y. T., Pende, D., Maul-Pavicic, A., Gilmour, K. C., Ufheil, H., Vraetz, T., Chiang, S. C., Marcenaro, S., Meazza, R., Bondzio, I., Walshe, D., Janka-Schaub, G., Lehmberg, K., Beutel, K., Zur Stadt, U., Binder, N., Arico, M., Moretta, L., Henter, J-I. & Ehl, S., 2012, In: BLOOD. 119, 12, p. 2754-2763 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.

    Sperl, D., Benesch, M., Urban, C., Lackner, H., Sovinz, P., Speicher, M. R., Uhrig, S., Schwarzbraun, T., Schwinger, W., Zur Stadt, U., Beutel, K., Janka-Schaub, G., Scarpatetti, M. & Seidel, M. G., 2012, In: KLIN PADIATR. 224, 6, p. 386-389 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. In vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.

    Terziyska, N., Catarina, C. A., Groiss, V., Schneider, K., Farkasova, K., Ogris, M., Wagner, E., Ehrhardt, H., Brentjens, R. J., Zur Stadt, U., Horstmann, M., Quintanilla-Martinez, L. & Jeremias, I., 2012, In: PLOS ONE. 7, 12, p. 52798 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR).

    Weber, A., Taube, S., Zur Stadt, U., Horstmann, M., Krohn, K., Bradtke, J., Teigler-Schlegel, A., Leiblein, S. & Christiansen, H., 2012, In: EXP HEMATOL ONCOL. 1, 1, p. 33 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  55. Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis.

    Bode, S. F., Lehmberg, K., Maul-Pavicic, A., Vraetz, T., Janka-Schaub, G., Zur Stadt, U. & Ehl, S., 2012, In: ARTHRITIS RES THER. 14, 3, p. 213 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  56. 2011
  57. Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3.

    Sieni, E., Cetica, V., Santoro, A., Beutel, K., Mastrodicasa, E., Meeths, M., Ciambotti, B., Brugnolo, F., Zur Stadt, U., Pende, D., Moretta, L., Griffiths, G. M., Henter, J-I., Janka-Schaub, G. & Aricò, M., 2011, In: J MED GENET. 48, 5, p. 343-352 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  58. Subtle differences in CTL cytotoxicity determine susceptibility to hemophagocytic lymphohistiocytosis in mice and humans with Chediak-Higashi syndrome.

    Jessen, B., Maul-Pavicic, A., Ufheil, H., Vraetz, T., Enders, A., Lehmberg, K., Längler, A., Gross-Wieltsch, U., Bay, A., Kaya, Z., Bryceson, Y. T., Koscielniak, E., Badawy, S., Davies, G., Hufnagel, M., Schmitt-Graeff, A., Aichele, P., Zur Stadt, U., Schwarz, K. & Ehl, S., 2011, In: BLOOD. 118, 17, p. 4620-4629 17.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  59. The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97).

    Escherich, G., Troeger, A. F., Gobel, U., Graubner, U., Pekrun, A., Jorch, N., Kaspers, G., Zimmermann, M., Zur Stadt, U., Kazemir, K., Pieters, R., Horstmann, M., Denboer, M. L. & Janka-Schaub, G., 2011, In: HAEMATOLOGICA. 96, 6, p. 854-862 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  60. 2010
  61. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases

    Rohr, J., Beutel, K., Maul-Pavicic, A., Vraetz, T., Thiel, J., Warnatz, K., Bondzio, I., Gross-Wieltsch, U., Schündeln, M., Schütz, B., Woessmann, W., Groll, A. H., Strahm, B., Pagel, J., Speckmann, C., Janka-Schaub, G., Griffiths, G., Schwarz, K., Zur Stadt, U. & Ehl, S., 12.2010, In: HAEMATOLOGICA. 95, 12, p. 2080-2087 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  62. Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia.

    Müller-Tidow, C., Klein, H-U., Hascher, A., Isken, F., Tickenbrock, L., Thoennissen, N., Agrawal-Singh, S., Tschanter, P., Disselhoff, C., Wang, Y., Becker, A., Thiede, C., Ehninger, G., Zur Stadt, U., Koschmieder, S., Seidl, M., Müller, F. U., Schmitz, W., Schlenke, P., McClelland, M., Berdel, W. E., Dugas, M., Serve, H. & Leukemia, S. A., 2010, In: BLOOD. 116, 18, p. 3564-3571 18.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  63. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5.

    Cetica, V., Santoro, A., Gilmour, K. C., Sieni, E., Beutel, K., Pende, D., Marcenaro, S., Koch, F., Grieve, S., Wheeler, R., Zhao, F., Zur Stadt, U., Griffiths, G. M. & Aricò, M., 2010, In: J MED GENET. 47, 9, p. 595-600 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  64. 2009
  65. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11

    zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., Strauss, J., Kasper, B., Nürnberg, G., Becker, C., Maul-Pavicic, A., Beutel, K., Janka, G., Griffiths, G., Ehl, S. & Hennies, H. C., 10.2009, In: AM J HUM GENET. 85, 4, p. 482-492 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next